What was missing in this update vs the last update was the chart below ( from ASX release on 26/8/24 ). This update was not as comprehensive as the August update .... which makes people suspicious, and could be the reason for some of the selling :
I found this useful as it tracked the individuals scores. As we discussed at the time, 2 has poor ALSFRS-S scores, and one had dropped significantly. I'm guessing one of these patients has subsequently died, and if it is the patient that dropped 6 points to 13 in the August update, dropping another 13 points would have had a significant impact on the overall score.
This chart also highlighted the 5 patients had maintained stable ALSFRS-S scores. I would appreciate an update on the status of these 5 patients individual scores.
The devil is in the detail ... we don't have the detail ! But if my suspicions are right, we essentially have 5 patients performing well, and 3 not. I guess this is why we are delving into genetics, to see if there is a reason why some patients are responding better than others.
NUZ Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)